Bitterman Chris T. 4
4 · CUMBERLAND PHARMACEUTICALS INC · Filed Mar 27, 2023
Insider Transaction Report
Form 4
Bitterman Chris T.
Vice Pres Sales & Marketing
Transactions
- Award
Options (right to buy)
2023-03-24+5,500→ 12,500 totalExercise: $1.97From: 2027-03-24Exp: 2033-03-24→ Common Stock (5,500 underlying)